Skip to main content
Clinical Trials/NCT02227524
NCT02227524
Completed
Not Applicable

Trekking Poles to Aid Multiple Sclerosis Gait Impairment

Rowan University1 site in 1 country29 target enrollmentApril 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Rowan University
Enrollment
29
Locations
1
Primary Endpoint
Composite measures of walking
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

In this study, the investigators will examine a sample of persons with multiple sclerosis (MS) to determine whether their walking function and ability is different depending on which walking assistive device is used.

Detailed Description

In this study, the investigators will examine a sample of persons with multiple sclerosis (MS) to determine whether their walking function and ability is different depending on which walking assistive device is used. In addition, the investigators will examine the psychosocial impact and amount of fatigue induced by each assistive device. Data collection will consist of a series of assessments via survey and physical performance. The analyses will consist of appropriate comparisons of means to determine if the use of different assistive devices alters any of the outcomes.

Registry
clinicaltrials.gov
Start Date
April 2014
End Date
March 7, 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eric Gregory

Director of Research Compliance

Rowan University

Eligibility Criteria

Inclusion Criteria

  • Be 18-64 years old with a confirmed diagnosis of MS
  • Have perceived walking difficulty
  • Have an EDSS score of \< 6, calculated by the physician
  • Ability to understand study procedures and to comply with them for the entire length of the study

Exclusion Criteria

  • Have had a MS exacerbation in the prior 8 weeks
  • Have other serious medical conditions that would impair their ability to participate in gait performance testing (i.e. severe rheumatoid arthritis or osteoarthritis)
  • If the physician deems a participant unsafe to go home with devices
  • Cannot communicate in English
  • Possess greater than a mild decrease in mentation (i.e. a score of \>2 on the Mental Functions item of the FSS)
  • Inability or unwillingness of individual to give written informed consent

Outcomes

Primary Outcomes

Composite measures of walking

Time Frame: 1 year

Temporal and spatial parameters of gait/walking (measured with the GAITRite portable walkway system)

Study Sites (1)

Loading locations...

Similar Trials